Kingston AE - Search Results

1

Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo.

Sharpe EF, Kingston AE, Lodge D, Monn JA, Headley PM. Sharpe EF, et al. Among authors: kingston ae. Br J Pharmacol. 2002 Mar;135(5):1255-62. doi: 10.1038/sj.bjp.0704583. Br J Pharmacol. 2002. PMID: 11877334 Free PMC article.

2

A novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices.

Doherty AJ, Palmer MJ, Bortolotto ZA, Hargreaves A, Kingston AE, Ornstein PL, Schoepp DD, Lodge D, Collingridge GL. Doherty AJ, et al. Among authors: kingston ae. Br J Pharmacol. 2000 Sep;131(2):239-44. doi: 10.1038/sj.bjp.0703574. Br J Pharmacol. 2000. PMID: 10991916 Free PMC article.

3

Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo.

Bond A, Jones NM, Hicks CA, Whiffin GM, Ward MA, O'Neill MF, Kingston AE, Monn JA, Ornstein PL, Schoepp DD, Lodge D, O'Neill MJ. Bond A, et al. Among authors: kingston ae. J Pharmacol Exp Ther. 2000 Sep;294(3):800-9. J Pharmacol Exp Ther. 2000. PMID: 10945827

4

Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795.

Kingston AE, O'Neill MJ, Lam A, Bales KR, Monn JA, Schoepp DD. Kingston AE, et al. Eur J Pharmacol. 1999 Jul 21;377(2-3):155-65. doi: 10.1016/s0014-2999(99)00397-0. Eur J Pharmacol. 1999. PMID: 10456425

5

DHPG-induced LTD in area CA1 of juvenile rat hippocampus; characterisation and sensitivity to novel mGlu receptor antagonists.

Fitzjohn SM, Kingston AE, Lodge D, Collingridge GL. Fitzjohn SM, et al. Among authors: kingston ae. Neuropharmacology. 1999 Oct;38(10):1577-83. doi: 10.1016/s0028-3908(99)00123-9. Neuropharmacology. 1999. PMID: 10530819

6

The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity.

Fitzjohn SM, Bortolotto ZA, Palmer MJ, Doherty AJ, Ornstein PL, Schoepp DD, Kingston AE, Lodge D, Collingridge GL. Fitzjohn SM, et al. Among authors: kingston ae. Neuropharmacology. 1998 Dec;37(12):1445-58. doi: 10.1016/s0028-3908(98)00145-2. Neuropharmacology. 1998. PMID: 9886667

7

Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors.

Kingston AE, O'Neill MJ, Bond A, Bruno V, Battaglia G, Nicoletti F, Harris JR, Clark BP, Monn JA, Lodge D, Schoepp DD. Kingston AE, et al. Ann N Y Acad Sci. 1999;890:438-49. doi: 10.1111/j.1749-6632.1999.tb08022.x. Ann N Y Acad Sci. 1999. PMID: 10668448

8

Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039).

Rorick-Kehn LM, Johnson BG, Burkey JL, Wright RA, Calligaro DO, Marek GJ, Nisenbaum ES, Catlow JT, Kingston AE, Giera DD, Herin MF, Monn JA, McKinzie DL, Schoepp DD. Rorick-Kehn LM, et al. Among authors: kingston ae. J Pharmacol Exp Ther. 2007 Apr;321(1):308-17. doi: 10.1124/jpet.106.110809. Epub 2007 Jan 4. J Pharmacol Exp Ther. 2007. PMID: 17204749

9

Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.

Monn JA, Valli MJ, Massey SM, Hansen MM, Kress TJ, Wepsiec JP, Harkness AR, Grutsch JL Jr, Wright RA, Johnson BG, Andis SL, Kingston A, Tomlinson R, Lewis R, Griffey KR, Tizzano JP, Schoepp DD. Monn JA, et al. J Med Chem. 1999 Mar 25;42(6):1027-40. doi: 10.1021/jm980616n. J Med Chem. 1999. PMID: 10090786

10

Methyl substitution of 2-aminobicyclo[3.1.0]hexane 2,6-dicarboxylate (LY354740) determines functional activity at metabotropic glutamate receptors: identification of a subtype selective mGlu2 receptor agonist.

Dominguez C, Prieto L, Valli MJ, Massey SM, Bures M, Wright RA, Johnson BG, Andis SL, Kingston A, Schoepp DD, Monn JA. Dominguez C, et al. J Med Chem. 2005 May 19;48(10):3605-12. doi: 10.1021/jm040222y. J Med Chem. 2005. PMID: 15887967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page